Interleukin 10  gene rs1800896 polymorphism is associated with the risk of prostate cancer

Hao Chen; Jilei Tang; Nan Shen; Kewei Ren

doi:10.18632/oncotarget.19857

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer

Hao Chen, Jilei Tang, Nan Shen and Kewei Ren _

PDF | HTML | How to cite

Oncotarget. 2017; 8:66204-66214. https://doi.org/10.18632/oncotarget.19857

Metrics: PDF 1148 views | HTML 2494 views | ?

Abstract

Hao Chen1, Jilei Tang2, Nan Shen3 and Kewei Ren4

1Department of Urology, The First Hospital of Jiaxing, Jiaxing 314001, China

2Department of Orthopedics, Qidong People’s Hospital, Nantong 226200, China

3Department of Clinical Pharmacy, The Affiliated Jiangyin Hospital of Southeast University Medical School, Jiangyin 214400, China

4Department of Orthopedics, The Affiliated Jiangyin Hospital of Southeast University Medical School, Jiangyin 214400, China

Correspondence to:

Kewei Ren, email: [email protected]

Keywords: interleukin-10, polymorphism, prostate cancer, meta-analysis

Received: May 10, 2017 Accepted: June 30, 2017 Published: August 03, 2017

ABSTRACT

Numerous studies have uncovered the association of Interleukin-10 (IL-10) gene rs1800896 polymorphism with the risk of prostate cancer (PCa); however, their conclusions were inconsistent. Therefore, we conducted this meta-analysis to evaluate the role of IL-10 rs1800896 polymorphism in the risk of PCa. 16 eligible studies in 15 articles involving 6,301 cases and 6,510 controls were identified by researching PubMed, Google, CNKI, and EMBASE up to April 1, 2017. Our results revealed that IL-10 rs1800896 polymorphism was associated with the decreased risk of PCa under the homozygous model. Subgroup analysis by ethnicity revealed that rs1800896 polymorphism decreased the risk of PCa among Caucasians. In conclusion, IL-10 gene rs1800896 polymorphism is associated with the decreased risk of PCa. Larger studies with more diverse ethnic populations are needed to confirm these results.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19857

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer

Abstract